Literature DB >> 19062633

PEGylation: an approach for drug delivery. A review.

Aviral Jain1, Sanjay K Jain.   

Abstract

The current review presents an update on polyethylene glycol (PEG), which is widely used as a covalent modifier of macromolecules. This review discusses the polymers suitable for conjugation, their conjugation methods, and their properties. Proteins and bioactive substances can be chemically modified by binding synthetic macromolecules of PEG to the surface of these biomolecules. Protein and peptide PEGylation improves the biopharmaceutical properties of drugs-that is, increased stability, increased resistance to proteolytic inactivation, decreased to nonexistent immunogenicity, increased circulatory lives, and low toxicity. These altered properties improve the delivery and efficacy of proteins.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19062633     DOI: 10.1615/critrevtherdrugcarriersyst.v25.i5.10

Source DB:  PubMed          Journal:  Crit Rev Ther Drug Carrier Syst        ISSN: 0743-4863            Impact factor:   4.889


  38 in total

1.  Nanoliposomal delivery of cytosolic phospholipase A2 inhibitor arachidonyl trimethyl ketone for melanoma treatment.

Authors:  Raghavendra Gowda; Saketh S Dinavahi; Soumya Iyer; Shubhadeep Banerjee; Rogerio I Neves; Colette R Pameijer; Gavin P Robertson
Journal:  Nanomedicine       Date:  2018-01-06       Impact factor: 5.307

2.  [Pegylated interferon beta 1a. A new therapy option for treatment of relapsing-remitting multiple sclerosis].

Authors:  V I Leussink; C Warnke; B Tackenberg; H Wiendl; B C Kieseier
Journal:  Nervenarzt       Date:  2015-04       Impact factor: 1.214

3.  Site specific discrete PEGylation of (124)I-labeled mCC49 Fab' fragments improves tumor MicroPET/CT imaging in mice.

Authors:  Haiming Ding; Michelle M Carlton; Stephen P Povoski; Keisha Milum; Krishan Kumar; Shankaran Kothandaraman; George H Hinkle; David Colcher; Rich Brody; Paul D Davis; Alex Pokora; Mitchell Phelps; Edward W Martin; Michael F Tweedle
Journal:  Bioconjug Chem       Date:  2013-10-31       Impact factor: 4.774

4.  Antibody fragments: hope and hype.

Authors:  Aaron L Nelson
Journal:  MAbs       Date:  2010-01-27       Impact factor: 5.857

5.  Interrelationship of steric stabilization and self-crowding of a glycosylated protein.

Authors:  R Høiberg-Nielsen; P Westh; L K Skov; L Arleth
Journal:  Biophys J       Date:  2009-09-02       Impact factor: 4.033

6.  Emerging synthetic approaches for protein-polymer conjugations.

Authors:  Rebecca M Broyer; Gregory N Grover; Heather D Maynard
Journal:  Chem Commun (Camb)       Date:  2011-01-12       Impact factor: 6.222

7.  Noninvasive imaging of lipid nanoparticle-mediated systemic delivery of small-interfering RNA to the liver.

Authors:  Weikang Tao; Joseph P Davide; Mingmei Cai; Guo-Jun Zhang; Victoria J South; Andrea Matter; Bruce Ng; Ye Zhang; Laura Sepp-Lorenzino
Journal:  Mol Ther       Date:  2010-07-13       Impact factor: 11.454

Review 8.  Diffusion of macromolecules in the brain: implications for drug delivery.

Authors:  Daniel J Wolak; Robert G Thorne
Journal:  Mol Pharm       Date:  2013-01-31       Impact factor: 4.939

9.  Focal, remote-controlled, chronic chemical modulation of brain microstructures.

Authors:  Khalil B Ramadi; Canan Dagdeviren; Kevin C Spencer; Pauline Joe; Max Cotler; Erin Rousseau; Carlos Nunez-Lopez; Ann M Graybiel; Robert Langer; Michael J Cima
Journal:  Proc Natl Acad Sci U S A       Date:  2018-06-25       Impact factor: 11.205

10.  Pharmaceutical differences between block copolymer self-assembled and cross-linked nanoassemblies as carriers for tunable drug release.

Authors:  Hyun Jin Lee; Younsoo Bae
Journal:  Pharm Res       Date:  2012-10-09       Impact factor: 4.200

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.